Vail Health’s Pioneering Study of Psilocybin’s Effects on Depression Kicks off Next Month

March 21, 2025

(Vail Daily) In April, Vail Health’s Behavioral Health Innovation Center will kick off the second of two studies aimed at targeting depression. The OPTIMIZE study will examine the impacts of psilocybin, the active ingredient in psychedelic mushrooms, on people with major depressive disorder.

OPTIMIZE Study to Examine Impact of Psilocybin on Depression

February 27, 2025

By Deidre Satterfield

The OPTIMIZE Study will explore innovative methods to amplify the effects of psilocybin on depression and anxiety through the co-administration of non-invasive vagus nerve stimulation.

What Experts Say About Taking Psilocybin as an Alternative Treatment for Depression

October 22, 2024

By Deidre Satterfield

(CNN) For a good number of people antidepressants have been a blessing, at least at the beginning of treatment, but for up to a third of depressed patients, antidepressants fail to work at all, said Dr. Charles Raison.

Tag: clinical depression